Abstract
Interaction between anti-inflammatory drugs and reactive oxygen metabolites must be considered in the course of pharmacological studies intended to develop new compounds. Effects of indomethacin, aspirin, and 3,5-diisopropylsalicylic acid (3,5-DIPS) and their copper complexes on PMNL oxidative metabolism and the evolution of an acute inflammatory reaction were studied in the rat.
Experiments were performedin vitro by assessment of superoxide generation and reduction of chemiluminescence by PMNLs incubated or not (control) in medium containing various concentrations of these compounds.
A dose-related decrease of these parameters was observed, however, copper complexes were found to be more effective than their parent drugs or Cu gluconate. Copper complexes were also more effective anti-inflammatory agents than their parent ligands or Cu gluconate when the volume of exudate and number of exudate PMNLs were assessed after induction of plerisy in rats by injection of isologous serum.
It is concluded that modulation of the PMNL oxidative burst by copper complexes offers an accounting for the anti-inflammatory activity of these compounds.
References
J. A. Fee,Is superoxide important in oxygen poisoning? Trends Biochem. Sci.7, 84–86 (1982).
H. L. Malech and I. I. Gallin,Neutrophils in human diseases. New Engl. J. Med.291, 642–646 (1987).
J. L. Marx,Oxygen free radicals linked to many diseases. Science235, 529–531 (1987).
E. Arrigoni-Martelli,Pharmacology of free radical scavenging in inflammation. Int. J. Tiss. React.7, 513–519 (1985).
L. Flohé, H. Giertz and R. Beckmann,Free radical scavengers as anti-inflammatory drugs? In Handboock of Inflammation Vol. 5 (Eds. I. L. Bonta, M. A. Bray and M. J. Parnham) pp. 255–281, Elsevier, Amsterdam 1985.
F. T. Greenaway, L. J. Norris and J. R. J. Sorenson,Mononuclear and binuclear copper (II) complexes of 3,5-diisopropylsalicylic acid. Inorganica Chim. Acta145, 279–284 (1988).
J. R. J. Sorenson,Copper complexes — a unique class of antiarthritic drugs. InProgress in Medicinal Chemistry, vol 15 (Eds. G. B. Ellis and G. B. West) pp. 211–260, Elsevier, Amsterdam 1978.
J. R. J. Sorenson,Copper chelates as possible active forms of antiarthritic agents. J. Med. Chem.19, 135–148 (1976).
J. R. J. Sorenson,The anti-flammatory activities of some copper complexes. InMetal ions in Biological Systems, vol. 14 (Ed. H. Sigel) pp. 77–124, Marcel Dekker, New York 1982.
J. R. J. Sorenson,Copper complexes offer a physiologic approach to treatment of ulcer disease. New Aspects of Pathogenesis and Pharmacology. (Eds. S. Szabo and C. J. Pfeiffer) in press, CRC Press, Boca Raton 1989.
J. M. McCord and R. S. Roy,The pathophysiology of superoxide: roles in inflammation and ischemia. Can. J. Physiol. Pharmacol.60, 1346–1352 (1982).
H. J. Hartmann, A. Gartner and V. Weser,Copper dependent control of the enzymic and phagocyte induced degradation of some biopolymers, a possible link to systemic inflammation. Clin. Chim. Acta152, 95–103 (1985).
M. C. Cassone,Azione di salicilati sulla scomparsa di batteri (Lactobacillus casii)fagociti da polimorfonucleati. Boll. Soc. Ital. Biol. Sper.58, 371–377 (1982).
J. V. Hurley, G. B. Ryan and A. Friedman,The mononuclear response to intrapleural injection in the rat. J. Path. Bact.91, 575–587 (1966).
J.-P. Giroud, M. Roch-Arveiller and O. Muntaner,Prélèvement répété des polynucléaires dans la cavité pleurale du Rat. Application à l'étude du chimiotactisme. Nelle Rev. Fse Hemat.20, 535–543 (1978).
R. C. Allen, R. L. Stjernholm and R. H. Steel,Evidence for the generation of an electronic state (s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem. Biophys. Res. Comm.47, 679–684 (1972).
R. Johnston, B. B. Kell, H. P. Misra, J. E. Lehmeyer, L. S. Webb, R. L. Baehner and K. V. Rajacopalan,The role of superoxide anion generation in phagocytic bactericidal activity. J. Clin. Invest.55, 1357–1372 (1975).
J. R. J. Sorenson,Copper complexes offer a physiological approach to treatment of chronic diseases. Prog. in Med. Chem.26, 437–568 (1987).
T. M. Neal, M. C. M. Vissers and C. C. Winterbourn,Inhibition by non-steroidal anti-inflammatory drugs of superoxide production and granule enzyme release by polymorphonuclear leukocytes stimulated with immune complexes or formylmethionyl-leucyl-phenylalanine. Biochem. Pharmacol.36, 2511–2517 (1987).
L. Simchovitz, J. Mehta and I. Spilberg,Chemotactic factorinduced generation of superoxide radicals by human neutrophils. Arthr. and Rheum.22, 755–763 (1979).
J. E. Smolen and G. Weissmann,Effects of indomethacin, 5.8.11.14-eicosatetraenoic acid and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes. Biochem. Pharmacol.29, 533–538 (1980).
M. M. Dale and A. Penfield,Comparison of the effects of indomethacin, RHC 80267 and R 59022 on superoxide production by 1-oleoyl-2-acetylglycerol and A 23187 in human neutrophils. Brit. J. Pharmacol.92, 63–68 (1987).
J. C. Gay, J. C. Lukens and D. K. English,Differential inhibition of neutrophil superoxide generation by non-steroidal anti-inflammatory drugs. Inflammation8, 209–292 (1984).
I. M. Goldstein,Agents that interfere with arachidonic acid metabolism. InInflammation, Basic Principles and Clinical Correlates. (Eds J. I. Gallin, I. M. Goldstein and R. Snyderman) pp. 935–946, Raven Press, New York 1988.
J. A. Simpson, K. H. Cheeseman, S. E. Smith and R. T. Dean,Free radical generation by copper ions and hydrogen peroxide. Stimulation by HEPES buffer. Biochem. J.254, 519–523 (1988).
B. Halliwell and J. M. C. Gutteridge,Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J.219, 1–14 (1984).
Farhataziz and A. B. Ross,Selected specific rates of reactions of transients from water in aqueous solutions. U.S. Government, Printing Office, Washington (1977).
H. Sigel,Catalase and peroxidase activity of Cu 2+ complexes. Angew. Chem. Internat. Edn.8, 167–177 (1969).
G. A. Reed and C. Madhu,Peroxide scavenging by Cu (II) sulfate and Cu (II) (3-5-diisopropylsalicylate) 2. InBiology of Copper Complexes (Ed J. R. J. Sorenson) pp. 287–298, Humana Press, Clifton, New Jersey (1987).
A. Bast,Is formation of reactive oxygen by cytochrome P-450 perilous and predictable? Trends Pharmacol. Sci.7, 266–270 (1986).
J. Bjork, R. F. Del Maestro and K. E. Arfors,Evidence for participation of hydroxyl radical in increased microvascular permeability. Agents and Actions10 (Suppt), 208–212 (1980).
W. J. Baader, A. Hatzelmann and V. Ullrich,The suppression of granulocyte functions by lipophilic antioxidants. Biochem. Pharmacol.37, 1089–1098 (1988).
P. J. Flynn, W. K. Becker, G. M. Vercelotti, D. J. Weisdorf, P. R. Craddock, D. E. Hammerschmidt, R. C. Lillehei and H. S. Jacob,Ibuprofen inhibits granulocyte responses to inflammatory mediators, Inflammation8, 33–44 (1984).
R. E. Muid, B. Twomey and M. M. Dale,The effect of inhibition of both diacylglycerol metabolism and phopholipase A2 activity on superoxide generation by human neutrophils. FEBS Let.234, 235–240 (1988).
K. Taniguchi, M. Urakami and K. Takanaka,Effects of various drugs on superoxide generation, arachidonic acid release and phospholipase A2 in polymorphonuclear leukocytes. Japan J. Pharmacol.46, 275–284 (1988).
J. R. J. Sorenson,Bis (3-5-diisopropylsalicylate) copper II, a potent radioprotectant with superoxide dismutase mimetic activity. J. Med. Chem.27, 1747–1749 (1984).
J. R. J. Sorenson,Copper complexes: a physiologic approach to treatment of chronic diseases. Compr. Ther.11, 49–64 (1985).
J. R. J. Sorenson, L. S. F. Soderberg, M. L. Baker, J. B. Barnett, L. W. Chang, H. Salari and W. M. Willingham,Radiation recovery agents: Cu (II) Mn (II) Zn (II) or Fe (III) 3-5-diisopropylsalicylate complexes facilitate recovery from ionizing radiation induced radical mediated tissue damage. Proc. Soc. of Free Radical Research, Paris, Dec. 1988 (1989).
M. Wasil, B. Halliwell, C. P. Moorhouse, C. Duncan, S. Hutchinson and H. Baum,Biologically significant scavenging of the myeloperoxydase-derived oxidant hypochlorous acid by some anti-inflammatory drugs. Biochem. Pharmacol.36, 3847–3850 (1987).
T. W. Kensler and M. A. Trush,Inhibition of oxygen radical metabolism in phorbol ester-activated polymorphonuclear leukocytes by an antitumor promoting copper complex with superoxide dismutase-mimetic activity. Biochem. Pharmacol.32, 3485–87 (1983).
R. A. Lovstad,Copper catalysed oxidation of ascorbate (vitamin C): Inhibitory effect of catalase, superoxide dismutase, serum proteins (coeruloplasmin, albumin, apotransferrin) and aminoacids. Int. J. Biochem.19, 309–313 (1987).
M. Roch-Arveiller, D. Pham Huy, L. Maman, J. P. Giroud and J. R. J. Sorenson,Modulating of polymorphonuclear leukocyte migration offers an accouting for the increased effectiveness of non-steroidal anti-inflammatory drug copper complexes. Biochem. Pharmacol. (in press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roch-Arveiller, M., Revelant, V., Huy, D.P. et al. Effects of some non-steroidal anti-inflammatory drug copper complexes on polymorphonuclear leukocyte oxidative metabolism. Agents and Actions 31, 65–71 (1990). https://doi.org/10.1007/BF02003223
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02003223